Featured Articles

Antidepressants in Bipolar [60 Sec Psych]

By: jives | May 28th , 2020 | Podcast| 4 Comment

Do they help? Do they harm? And can mood stabilizers protect patients who take them? A review of Bahji A, Ermacora D, Stephenson C, Hawken ER, Vazquez G. Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis. J Affect Disord. 2020;269:154‐184.

Read More

How to Dose an Antidepressant

By: jives | April 3rd , 2020 | Podcast| 1 Comment

Some antidepressants get better as the dose goes higher, while others just fizzle. For older patients, the side effects stack up as the benefits plateau. We review 3 new meta-analyses on antidepressant dosing, and bring you 4 updates on how the coronavirus is changing practice regulation. Date Published: 3/30/2020 Duration: 27 minutes, 2 secon

Read More

Editor's Choice: An Antidepressant Diet Expert Q&A

By: jives | July 11th , 2019 | The Carlat Psychiatry Blog| 0 Comment

I was a reader of The Carlat Psychiatry Report before I was an editor, and there were two things that led me to subscribe to it: 1) They cover topics that get missed in the psychiatric press, like practical tips and treatments that aren't backed by a promotional budget. 2) They give the big picture and the nitty gritty. Instead of reciting the researc

Read More

SSRI Withdrawal

By: jives | July 1st , 2019 | Podcast| 0 Comment

Withdrawal problems rank among patients’ top concerns with antidepressants. They include insomnia, flu-like symptoms, irritability, distractibility, and unusual sensory experiences such as “brain zaps.” Earlier this year, a study examined clinical and biological research on tapers of serotonergic antidepressants. In this episode we discuss wha

Read More

Prescribing Newer Antidepressants

By: jives | May 3rd , 2019 | The Carlat Psychiatry Blog| 0 Comment

Michael Gitlin, MD, director of the Outpatient Mood Disorder Program at UCLA gave The Carlat Psychiatry Report his view on newer antidepressants. He emphasized that these newer medications are no more effective than our standard antidepressants, but that it’s always good to have more options available for patients who may not have responded to—or wh

Read More